United States · FDA National Drug Code directory
CYFENDUS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71665-001_56348c77-08d5-aeb2-e063-6394a90af528
- Product NDC
- 71665-001
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Anthrax Vaccine Adsorbed, Adjuvanted
- Labeler
- Emergent Product Development Gaithersburg Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230919
- Source listing expiry
- 20271231
Source-listed ingredients
- BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS — 100 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (71665-001-02) / 5 mL in 1 VIAL, MULTI-DOSE (71665-001-01) · 71665-001-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →